Æ÷À¯·ù ¼¼Æ÷ ¹ßÇö ŰƮ ½ÃÀå : Á¦Ç° À¯Çüº°, ¹ßÇö ½Ã½ºÅÛº°, ¿ëµµº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2024-2032³â)
Mammalian Cell Expression Kits Market, By Product Type, By Expression System, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
»óǰÄÚµå : 1532836
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2024³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 377 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,574,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,544,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 7,952,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

º¸°í¼­ ÇÏÀ̶óÀÌÆ®

Æ÷À¯·ù ¼¼Æ÷ ¹ßÇö ŰƮ ½ÃÀå ±Ô¸ð´Â 2023³â 29¾ï 9,834¸¸ ´Þ·¯·Î 2024³âºÎÅÍ 2032³â±îÁö CAGR 6.98%·Î È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Æ÷À¯·ù ¼¼Æ÷ ¹ßÇö ŰƮ ½ÃÀå - ½ÃÀå ¿ªÇÐ

Ä¡·á¿ë ´Ü¹éÁú »ý»ê ¹× ½Å¾à °³¹ß ºÐ¾ßÀÇ ÀÀ¿ë ºÐ¾ß Áõ°¡·Î Æ÷À¯·ù ¼¼Æ÷ ¹ßÇö ŰƮ ½ÃÀåÀÇ ¼ºÀå ÃËÁø

Æ÷À¯·ù ¼¼Æ÷ ¹ßÇö ŰƮ´Â Ä¡·á¿ë ´Ü¹éÁú »ý»ê ¹× ½Å¾à °³¹ß ºÐ¾ßÀÇ ÀÀ¿ë ºÐ¾ß°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Å°Æ®´Â Ä¡·á ¹× ¿¬±¸¿¡ ÀÚÁÖ »ç¿ëµÇ´Â º¹ÀâÇÑ ´Ü¹éÁú ¹× »ý¹°ÇÐÀû Á¦Á¦¸¦ »ý»êÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù. Æ÷À¯·ù ¼¼Æ÷ ¹ßÇö ŰƮ ½ÃÀåÀº Ä¡·á¿ë ´Ü¹éÁú »ý»ê ¹× ½Å¾à °³¹ß ºÐ¾ßÀÇ ÀÀ¿ë ºÐ¾ß°¡ Áõ°¡Çϸ鼭 Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ¹Ì±¹ ±¹¸³º¸°Ç¿ø(NIH)Àº Áö³­ 3³â°£ »ý¹°ÇÐ °ü·Ã ÇÁ·ÎÁ§Æ®¿¡ ´ëÇÑ ¿¬±¸ º¸Á¶±ÝÀÌ 25% Áõ°¡Çß´Ù°í º¸°íÇßÀ¸¸ç, ÀÌ´Â ´Ü¹éÁú ±â¹Ý Ä¡·á¹ý¿¡ ´ëÇÑ °ü½ÉÀÌ Áõ°¡Çϰí ÀÖÀ½À» º¸¿©ÁÝ´Ï´Ù. È­ÀÌÀÚ¿Í ¸ÓÅ©(Merck)¸¦ Æ÷ÇÔÇÑ ´ëÇü Á¦¾à»çµéÀº ÅõÀÚ¸¦ È®´ëÇϰí ÀÖÀ¸¸ç, È­ÀÌÀÚ´Â 2023³â±îÁö ¾à 17¾ï ´Þ·¯¸¦ »ý¹°ÇÐÀû Á¦Á¦ ¿¬±¸¿¡ ÅõÀÚÇÒ °èȹÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ÀÚ±Ý Á¶´Þ°ú ¿¬±¸ Ȱµ¿ÀÇ ±ÞÁõÀº Æ÷À¯·ù ¼¼Æ÷ ¹ßÇö ±â¼úÀÌ ÀǾàǰ °³¹ß ¹× Ä¡·á ¼Ö·ç¼ÇÀÇ ¹ßÀü¿¡ À־ Æ÷À¯·ù ¼¼Æ÷ ¹ßÇö ±â¼úÀÇ ¿ªÇÒÀÌ È®´ëµÇ°í ÀÖÀ½À» µÞ¹ÞħÇÕ´Ï´Ù.

Æ÷À¯·ù ¼¼Æ÷ ¹ßÇö ŰƮ ½ÃÀå - ÁÖ¿ä ÀλçÀÌÆ®

¸®¼­Ä¡ ¾Ö³Î¸®½ºÆ®ÀÇ ºÐ¼®¿¡ µû¸£¸é, ¼¼°è ½ÃÀåÀº ¿¹Ãø ±â°£(2024-2032³â) µ¿¾È ¸Å³â ¾à 6.98%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Á¦Ç° À¯Çüº°·Î´Â ŰƮ°¡ 2023³â °¡Àå Å« ½ÃÀå Á¡À¯À²À» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµÆ½À´Ï´Ù.

¹ßÇö ½Ã½ºÅÛ ¼¼ºÐÈ­¿¡ µû¸£¸é, 2023³â¿¡´Â CHO ¼¼Æ÷°¡ ÁÖ¿ä À¯ÇüÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù.

Áö¿ªº°·Î´Â ºÏ¹Ì°¡ 2023³â ÁÖ¿ä ¼öÀÍ¿øÀ¸·Î ºÎ»óÇß½À´Ï´Ù.

Æ÷À¯·ù ¼¼Æ÷ ¹ßÇö ŰƮ ½ÃÀå - ¼¼ºÐÈ­ ºÐ¼®:

¼¼°è Æ÷À¯·ù ¼¼Æ÷ ¹ßÇö ŰƮ ½ÃÀåÀº Á¦Ç° À¯Çü, ¹ßÇö ½Ã½ºÅÛ, ¿ëµµ ¹× Áö¿ª¿¡ µû¶ó ¼¼ºÐÈ­µË´Ï´Ù.

½ÃÀåÀº Á¦Ç° À¯Çü¿¡ µû¶ó 4°¡Áö·Î ºÐ·ùµË´Ï´Ù: ŰƮ´Â ÁÖ¿ä Á¦Ç° À¯ÇüÀ¸·Î ´Ü¹éÁú ¹ßÇöÀ» À§ÇÑ Á¾ÇÕÀûÀÎ ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù. ½Ã¾àÀº ´Ù¾çÇÑ »ýÈ­ÇÐ ¹ÝÀÀ¿¡ ÇʼöÀûÀ̸ç, ¼Ò¸ðǰ ¹× Àåºñ´Â Áö¼ÓÀûÀÎ ¿¬±¸ ¹× ¿î¿µ ¿ä±¸¸¦ Áö¿øÇϰí Àåºñ´Â °í±Þ ºÐ¼® ±â´ÉÀ» Á¦°øÇÕ´Ï´Ù.

½ÃÀåÀº ¹ßÇö ½Ã½ºÅÛ¿¡ µû¶ó CHO ¼¼Æ÷, HEK 293 ¼¼Æ÷, NS0 ¼¼Æ÷ÀÇ ¼¼ °¡Áö ¹üÁÖ·Î ³ª´µ¸ç, CHO ¼¼Æ÷´Â Ä¡·á¿ë ´Ü¹éÁú »ý»ê¿¡ ³Î¸® »ç¿ëµÇ±â ¶§¹®¿¡ ÁÖ¿ä ¹ßÇö ½Ã½ºÅÛÀÔ´Ï´Ù. ¶ÇÇÑ, HEK 293 ¼¼Æ÷´Â ÀϽÃÀûÀÎ ¹ßÇö È¿À²·Î ÀÎÇØ Áß¿äÇϸç, NS0 ¼¼Æ÷´Â Ç×ü »ý»êÀÇ Æ¯Á¤ ¿ëµµ¿¡ Ȱ¿ëµÇ°í ÀÖ½À´Ï´Ù.

Æ÷À¯·ù ¼¼Æ÷ ¹ßÇö ŰƮ ½ÃÀå - Áö¸®Àû ÀλçÀÌÆ®

ºÏ¹Ì´Â ¹ÙÀÌ¿ÀÀǾàǰ ¿¬±¸°³¹ß¿¡ ´ëÇÑ ¸·´ëÇÑ ÅõÀÚ¿Í ÅºÅºÇÑ »ý¸í°øÇÐ ÀÎÇÁ¶ó¸¦ ¹ÙÅÁÀ¸·Î ½ÃÀåÀ» ¼±µµÇϰí ÀÖÀ¸¸ç, ¹Ì±¹¸¸ÀÌ Àü ¼¼°è ¿¬±¸ ³ë·Â¿¡ Å« ±â¿©¸¦ Çϰí ÀÖ½À´Ï´Ù. µ¶ÀÏ, ¿µ±¹ µîÀÇ ±¹°¡µéÀÌ Çõ½ÅÀûÀÎ ½Å¾à °³¹ß ¹× Ä¡·áÁ¦ »ý»ê¿¡ ÁÖ·ÂÇϰí ÀÖÀ¸¸ç, À¯·´ÀÌ ±Ù¼ÒÇÑ Â÷ÀÌ·Î ±× µÚ¸¦ ÀÕ°í ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ƯÈ÷ Áß±¹°ú Àεµ¿¡¼­ ºü¸£°Ô ºÎ»óÇϰí ÀÖÀ¸¸ç, ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡¿Í Á¦¾à »ê¾÷ÀÇ È®ÀåÀÌ ¼ºÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¶óƾ¾Æ¸Þ¸®Ä«¿Í Áßµ¿ Áö¿ª¿¡¼­´Â ÀÇ·áºñ ÁöÃâ Áõ°¡¿Í ¿¬±¸ ¿ª·® È®´ë¿¡ ÈûÀÔ¾î Æ÷À¯·ù ¼¼Æ÷ ¹ßÇö ±â¼úÀÌ Á¡Â÷ÀûÀ¸·Î äÅõǰí ÀÖ½À´Ï´Ù.

Æ÷À¯·ù ¼¼Æ÷ ¹ßÇö ŰƮ ½ÃÀå - °æÀï »óȲ:

Thermo Fisher Scientific, Merck KGaA, GE Healthcare¿Í °°Àº ÁÖ¿ä ±â¾÷µéÀÌ Á¾ÇÕÀûÀÎ ¹ßÇö ŰƮ¿Í Áö¿ø ¼­ºñ½º¸¦ ÅëÇØ ½ÃÀåÀ» ¼±µµÇϰí ÀÖ½À´Ï´Ù. À̵é ÁÖ¿ä ±â¾÷µéÀº ±â¼ú Çõ½Å¿¡ ÁÖ·ÂÇϰí ÀÖÀ¸¸ç, Æ®·£½ºÆå¼Ç È¿À² Çâ»ó ¹× È®À强 °³¼±°ú °°Àº ÷´Ü ±â´ÉÀ» Æ÷ÇÔÇÏ´Â Á¦Ç° ¶óÀÎÀ» ÀÚÁÖ ¾÷µ¥ÀÌÆ®Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Àü·«Àû Á¦ÈÞ ¹× Àμö¸¦ ÅëÇØ ±â¼ú ¿ª·®À» °­È­ÇÏ°í ¼¼°è ÀÔÁö¸¦ È®´ëÇϱâ À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, Thermo Fisher ScientificÀÌ Æä³ð¿ùµå(Phenomworld)¸¦ ÀμöÇÔÀ¸·Î½á ÷´Ü ¼¼Æ÷ ºÐ¼® ±â¼ú ºÐ¾ßÀÇ ÀÔÁö¸¦ °­È­Çß½À´Ï´Ù. Áß¼Ò±â¾÷°ú Àü¹®¼ºÀÌ ³ôÀº »ý¸í°øÇÐ ±â¾÷µéµµ Æ´»õ ½ÃÀå°ú ÷´Ü ¼Ö·ç¼Ç¿¡ ÁýÁßÇÏ´Â °æ¿ì°¡ ¸¹¾Æ °æÀï ¿ªÇп¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ È°¹ßÇÑ °æÀï ȯ°æÀº Æ÷À¯·ù ¼¼Æ÷ ¹ßÇö ±â¼úÀÇ Áö¼ÓÀûÀÎ °³¼±°ú ±â¼ú Çõ½ÅÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Æ÷À¯·ù ¼¼Æ÷ ¹ßÇö ŰƮ ½ÃÀå °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Æ÷À¯·ù ¼¼Æ÷ ¹ßÇö ŰƮÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå Æ÷À¯·ù ¼¼Æ÷ ¹ßÇö ŰƮ »ê¾÷ ¿¬±¸

Á¦5Àå Æ÷À¯·ù ¼¼Æ÷ ¹ßÇö ŰƮ ½ÃÀå : COVID-19ÀÇ ¿µÇ⠺м®

Á¦6Àå Æ÷À¯·ù ¼¼Æ÷ ¹ßÇö ŰƮ ½ÃÀå »óȲ

Á¦7Àå Æ÷À¯·ù ¼¼Æ÷ ¹ßÇö ŰƮ ½ÃÀå - Á¦Ç° À¯Çüº°

Á¦8Àå Æ÷À¯·ù ¼¼Æ÷ ¹ßÇö ŰƮ ½ÃÀå - ¹ßÇö ½Ã½ºÅÛº°

Á¦9Àå Æ÷À¯·ù ¼¼Æ÷ ¹ßÇö ŰƮ ½ÃÀå - ¿ëµµº°

Á¦10Àå Æ÷À¯·ù ¼¼Æ÷ ¹ßÇö ŰƮ ½ÃÀå - Áö¿ªº°

Á¦11Àå ÁÖ¿ä º¥´õ ºÐ¼® - Æ÷À¯·ù ¼¼Æ÷ ¹ßÇö ŰƮ ¾÷°è

Á¦12Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§ Àü¸Á

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

REPORT HIGHLIGHT

Mammalian Cell Expression Kits Market size was valued at USD 2,998.34 Million in 2023, expanding at a CAGR of 6.98% from 2024 to 2032.

The Mammalian Cell Expression Kits Market involves tools designed for the production and analysis of proteins using mammalian cells. The demand for these kits is increasing due to their critical role in biopharmaceutical production, with major pharmaceutical companies investing over $5 billion annually in biologics development. However, high costs associated with advanced kits and technical complexities can be limiting factors. Opportunities are emerging through innovations in cell expression technologies and increasing applications in therapeutic protein production and drug discovery, with notable advancements in transfection efficiency and scalability offering the potential for market growth.

Mammalian Cell Expression Kits Market- Market Dynamics

Rising Applications in Therapeutic Protein Production and Drug Discovery Propel Mammalian Cell Expression Kits Market Growth

Mammalian cell expression kits are seeing growth due to their increasing use in therapeutic protein production and drug discovery. These kits are crucial for producing complex proteins and biologics that are often used in therapies and research. Rising applications in therapeutic protein production and drug discovery are significantly driving the Mammalian Cell Expression Kits Market. For example, the National Institutes of Health (NIH) reported a 25% increase in research grants for biologics-related projects over the past three years, highlighting the growing interest in protein-based therapies. Major pharmaceutical companies, including Pfizer and Merck, have ramped up their investments, with Pfizer allocating approximately USD 1.7 billion in 2023 for biologics research. This surge in funding and research activities underscores the expanding role of mammalian cell expression technologies in advancing drug development and therapeutic solutions.

Mammalian Cell Expression Kits Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.98% over the forecast period (2024-2032)

Based on product type segmentation, Kits was predicted to show maximum market share in the year 2023

Based on Expression System segmentation, CHO Cells were the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Mammalian Cell Expression Kits Market- Segmentation Analysis:

The Global Mammalian Cell Expression Kits Market is segmented based on Product Type, Expression System, Application, and Region.

The market is divided into four categories based on product type: Kits are the leading product type, offering comprehensive solutions for protein expression. Reagents follow, essential for various biochemical reactions, while Consumables and Instruments support ongoing research and operational needs, with Instruments providing advanced analytical capabilities.

The market is divided into three categories based on Expression System: CHO Cells, HEK 293 Cells, and NS0 Cells. CHO Cells are the predominant expression system due to their widespread use in therapeutic protein production. HEK 293 Cells are also significant for their efficiency in transient expression, while NS0 Cells are utilized for specific applications in antibody production.

Mammalian Cell Expression Kits Market- Geographical Insights

North America leads the market, driven by substantial investments in biopharmaceutical R&D and a well-established biotechnology infrastructure, with the United States alone contributing significantly to global research efforts. Europe follows closely, with countries like Germany and the UK focusing heavily on innovative drug discovery and therapeutic production. The Asia-Pacific region is rapidly emerging, particularly in China and India, where increasing investments in biotechnology and expanding pharmaceutical industries are fueling growth. Additionally, regions like Latin America and the Middle East are gradually adopting mammalian cell expression technologies, supported by rising healthcare expenditures and expanding research capabilities.

Mammalian Cell Expression Kits Market- Competitive Landscape:

Major companies such as Thermo Fisher Scientific, Merck KGaA, and GE Healthcare dominate the landscape with their comprehensive range of expression kits and support services. These leaders focus on innovation, frequently updating their product lines to include advanced features like higher transfection efficiencies and improved scalability. Additionally, they engage in strategic collaborations and acquisitions to enhance their technological capabilities and expand their global presence. For instance, Thermo Fisher Scientific's acquisition of Phenom-World has strengthened its position in advanced cell analysis technologies. Smaller players and specialized biotech firms also contribute to the competitive dynamics, often focusing on niche markets and cutting-edge solutions. This vibrant competitive environment drives continuous improvement and innovation in mammalian cell expression technologies.

Recent Developments:

In March 2022, ProteoGenix launched the XtenCHO Transient Expression System, designed to achieve up to ten times higher yields compared to existing CHO systems. This innovative system enhances plasmid stability and reduces hands-on time, streamlining early drug development processes.

In October 2020, Merck KGaA announced the expansion of its production capabilities with the inauguration of a new membrane manufacturing plant in Darmstadt, Germany. This facility aims to enhance the production of Millipore Express(R) membranes to meet growing market demands.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MAMMALIAN CELL EXPRESSION KITS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Agilent Technologies, Inc.

Bio-Rad Laboratories, Inc.

Bio-Techne Corporation

CellGenix GmbH

Danaher Corporation

Enzo Life Sciences, Inc.

GenScript Biotech Corporation

Horizon Discovery Group plc

Lonza Group AG

Merck KGaA

Promega Corporation

Qiagen N.V.

Sartorius AG

Sino Biological Inc.

Takara Bio Inc.

Thermo Fisher Scientific Inc.

Others

GLOBAL MAMMALIAN CELL EXPRESSION KITS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

GLOBAL MAMMALIAN CELL EXPRESSION KITS MARKET, BY EXPRESSION SYSTEM- MARKET ANALYSIS, 2019 - 2032

GLOBAL MAMMALIAN CELL EXPRESSION KITS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

GLOBAL MAMMALIAN CELL EXPRESSION KITS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

Table of Contents

1. Mammalian Cell Expression Kits Market Overview

2. Executive Summary

3. Mammalian Cell Expression Kits Key Market Trends

4. Mammalian Cell Expression Kits Industry Study

5. Mammalian Cell Expression Kits Market: COVID-19 Impact Analysis

6. Mammalian Cell Expression Kits Market Landscape

7. Mammalian Cell Expression Kits Market - By Product Type

8. Mammalian Cell Expression Kits Market - By Expression System

9. Mammalian Cell Expression Kits Market - By Application

10. Mammalian Cell Expression Kits Market- By Geography

11. Key Vendor Analysis- Mammalian Cell Expression Kits Industry

12. 360 Degree Analyst View

13. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â